Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA: 688192)
35.78
-1.81 (-4.82%)
Sep 6, 2024, 4:00 PM CST
Dizal (Jiangsu) Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 102.85 | 74.2 | 121.67 | 364.24 | 509.02 | 206.88 | Upgrade
|
Trading Asset Securities | 725.09 | 674 | 1,295 | 1,711 | 90.29 | 12.45 | Upgrade
|
Cash & Short-Term Investments | 827.93 | 748.2 | 1,416 | 2,075 | 599.31 | 219.32 | Upgrade
|
Cash Growth | -19.63% | -47.18% | -31.74% | 246.26% | 173.26% | -9.59% | Upgrade
|
Accounts Receivable | 93.7 | 48.04 | - | 7.55 | 6.9 | 9.95 | Upgrade
|
Other Receivables | - | - | - | - | - | 0.36 | Upgrade
|
Receivables | 93.99 | 48.04 | - | 7.55 | 6.9 | 10.31 | Upgrade
|
Inventory | 32.61 | 23.47 | 5.07 | - | - | - | Upgrade
|
Other Current Assets | 67.44 | 90.65 | 51.64 | 29.57 | 18.86 | 14.58 | Upgrade
|
Total Current Assets | 1,022 | 910.36 | 1,473 | 2,112 | 625.07 | 244.21 | Upgrade
|
Property, Plant & Equipment | 152.28 | 102.26 | 103.66 | 104.48 | 15.19 | 17.29 | Upgrade
|
Other Intangible Assets | 446.29 | 461.98 | 492.02 | 474.9 | 506.25 | 327.16 | Upgrade
|
Long-Term Deferred Charges | 12.84 | 16.99 | 7.99 | 4.54 | 3.53 | 0.07 | Upgrade
|
Other Long-Term Assets | 11.58 | 4.79 | 5.06 | 49.51 | 31.98 | 38.62 | Upgrade
|
Total Assets | 1,645 | 1,496 | 2,082 | 2,746 | 1,182 | 627.36 | Upgrade
|
Accounts Payable | 27.77 | 20.22 | 8.81 | 1.65 | 1.06 | 127.84 | Upgrade
|
Accrued Expenses | 230.66 | 177.08 | 208.53 | 182.75 | 94.26 | 25.17 | Upgrade
|
Short-Term Debt | 203.08 | 200.11 | - | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | 0.33 | 0.1 | - | - | - | - | Upgrade
|
Current Portion of Leases | 19.99 | 22.95 | 21.34 | 16.84 | - | - | Upgrade
|
Current Income Taxes Payable | - | 0.05 | 0 | - | 0.01 | 2.02 | Upgrade
|
Current Unearned Revenue | 1.92 | 0.98 | - | - | - | - | Upgrade
|
Other Current Liabilities | 62.33 | 26.93 | 9.82 | 10.76 | 7.79 | 21.92 | Upgrade
|
Total Current Liabilities | 546.08 | 448.44 | 248.49 | 211.99 | 103.11 | 176.96 | Upgrade
|
Long-Term Debt | 423.67 | 138.31 | - | - | - | - | Upgrade
|
Long-Term Leases | 39.15 | 48.89 | 63.93 | 70.92 | - | - | Upgrade
|
Long-Term Unearned Revenue | 14.56 | 12.11 | 11 | - | - | - | Upgrade
|
Total Liabilities | 1,023 | 647.75 | 323.43 | 282.91 | 103.11 | 176.96 | Upgrade
|
Common Stock | 415.65 | 408.15 | 407.16 | 404.18 | 360 | 1,095 | Upgrade
|
Additional Paid-In Capital | 3,052 | 2,954 | 2,757 | 2,729 | 718.88 | 0.12 | Upgrade
|
Retained Earnings | -2,858 | -2,514 | -1,406 | -669.85 | 0.03 | -645.01 | Upgrade
|
Shareholders' Equity | 621.51 | 848.63 | 1,758 | 2,463 | 1,079 | 450.4 | Upgrade
|
Total Liabilities & Equity | 1,645 | 1,496 | 2,082 | 2,746 | 1,182 | 627.36 | Upgrade
|
Total Debt | 686.21 | 410.37 | 85.27 | 87.76 | - | - | Upgrade
|
Net Cash (Debt) | 141.72 | 337.83 | 1,331 | 1,987 | 599.31 | 219.32 | Upgrade
|
Net Cash Growth | -83.67% | -74.62% | -33.02% | 231.62% | 173.26% | -9.59% | Upgrade
|
Net Cash Per Share | 0.34 | 0.83 | 3.29 | 5.52 | 1.67 | - | Upgrade
|
Filing Date Shares Outstanding | 415.65 | 408.15 | 407.16 | 404.18 | 360 | - | Upgrade
|
Total Common Shares Outstanding | 415.65 | 408.15 | 407.16 | 404.18 | 360 | - | Upgrade
|
Working Capital | 475.9 | 461.93 | 1,225 | 1,900 | 521.97 | 67.26 | Upgrade
|
Book Value Per Share | 1.47 | 2.08 | 4.32 | 6.09 | 3.00 | - | Upgrade
|
Tangible Book Value | 162.77 | 386.65 | 1,266 | 1,988 | 572.66 | 123.24 | Upgrade
|
Tangible Book Value Per Share | 0.39 | 0.95 | 3.11 | 4.92 | 1.59 | - | Upgrade
|
Machinery | 52.44 | 49.14 | 31.99 | 26.91 | 23.59 | 19.5 | Upgrade
|
Construction In Progress | 76.51 | 13.35 | 8.85 | 5.04 | 0.15 | 1.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.